Simultaneous PET/MRI: The future gold standard for characterizing motor neuron disease-A clinico-radiological and neuroscientific perspective.

Juengling, Freimut D; Wuest, Frank; Kalra, Sanjay; Agosta, Federica; Schirrmacher, Ralf; Thiel, Alexander; Thaiss, Wolfgang; Müller, Hans-Peter; Kassubek, Jan

Juengling, Freimut D; Wuest, Frank; Kalra, Sanjay; Agosta, Federica; Schirrmacher, Ralf; Thiel, Alexander; Thaiss, Wolfgang; Müller, Hans-Peter; Kassubek, Jan.

Afiliação

Juengling FD; Division of Oncologic Imaging, University of Alberta, Edmonton, AB, Canada.
Wuest F; Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, Canada.
Kalra S; Faculty of Medicine, University Bern, Bern, Switzerland.
Agosta F; Division of Oncologic Imaging, University of Alberta, Edmonton, AB, Canada.
Schirrmacher R; Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, Canada.
Thiel A; Department of Neurology, University of Alberta, Edmonton, AB, Canada.
Thaiss W; Division of Neuroscience, San Raffaele Scientific Institute, University Vita Salute San Raffaele, Milan, Italy.
Müller HP; Division of Oncologic Imaging, University of Alberta, Edmonton, AB, Canada.
Kassubek J; Medical Isotope and Cyclotron Facility, University of Alberta, Edmonton, AB, Canada.

Front Neurol ; 13: 890425, 2022.

Article em En | MEDLINE | ID: mdl-36061999

Palavras-chave

ALS; DTI; PET/MRI; SV2A; TrkB/BDNF; fMRI; motor neuron disease

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Front Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google